CNTX

Examining the Potential Price Growth of Context Therapeutics Inc (CNTX)
Daniel Torres
Context Therapeutics Inc’s filing revealed that its Chief Executive Officer Lehr Martin A. acquired Company’s shares for reported $70080.0 on ...

Context Therapeutics Inc’s filing revealed that its Chief Executive Officer Lehr Martin A. acquired Company’s shares for reported $70080.0 on ...